In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

reMYND NV

www.remynd.be

Latest From reMYND NV

Deal Watch: Boehringer's Busy End Of Year Includes Deals With Roche, Autifony

The German pharma options potassium channel modulator technology from Autifony and partners with Roche on immunological approaches to irritable bowel syndrome. Roche unveils discovery pacts with Confo and DiCE.

Deals Business Strategies

Deals Shaping the Medical Industry (10/2010)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions

Roche licenses neurodegenerative programmes

Roche has licensed two preclinical programmes focused on therapeutics to slow down neurodegenerative disorders from reMYND, a small Belgian biotechnology company. The deal that could be worth more than €500 million to reMYND in milestone and other payments, including an undisclosed upfront payment, plus royalties on any resulting product sales.

Metabolic Disorders Neurology
See All

Company Information

  • Industry
  • Biotechnology
    • Transgenics
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Belgium
  • Parent & Subsidiaries
  • reMYND NV
  • Senior Management
  • Hans van der Saag, CFO
    Gerard Griffioen, PhD, CSO
    Koen De Witte, Mng. Dir.
  • Contact Info
  • reMYND NV
    Phone: (32) 16 75 14 20
    Gaston Geenslaan 1
    Leuven, BE-3001
    Belgium
Advertisement
Advertisement
UsernamePublicRestriction

Register